Federal Health Grants

The Summer Research Education Experience Program (R25 Clinical Trial Not Allowed) is a federal funding opportunity administered by the National Institutes of Health, an agency within the U.S. Department of Health and Human Services. Multiple NIH institutes participate in this program, including the National Institute of Neurological Disorders and Stroke, National Eye Institute, National Institute on Drug Abuse, and others, each contributing mission-specific priorities. The program is designed to strengthen the biomedical, behavioral, and clinical research workforce by supporting structured educational experiences that complement existing training programs. The opportunity specifically emphasizes early-stage engagement in research through immersive summer experiences. The primary purpose of this program is to fund research education activities that provide hands-on, open-ended research experiences for high school students, undergraduate students, and high school science teachers. These activities are expected to occur during the summer academic break and include laboratory or field-based research aligned with NIH mission areas. In addition to research exposure, programs must incorporate complementary training such as scientific writing, presentation skills, and instruction in rigor and reproducibility. The overarching goal is to enhance participant knowledge, stimulate interest in research careers, and build a pipeline of future scientists. Funding supports programmatic costs associated with designing and implementing the research experience, including administrative personnel, participant compensation, and program-related expenses. Direct costs are capped at 125000 dollars per year, and project periods may extend up to five years. Allowable expenses include participant salaries, housing support, and limited travel, while certain costs such as faculty mentor salaries and general institutional administrative expenses are not permitted. No cost sharing or matching requirement is imposed. Participants must be engaged for a minimum of eight weeks and may participate up to the equivalent of fifteen weeks within a twelve month period. Eligibility for applicants is broad and includes higher education institutions, nonprofits, for profit organizations, and various government entities such as state, local, and tribal governments. However, foreign organizations and non domestic components are not eligible. Applicants must demonstrate institutional commitment, including adequate facilities, staff, and resources. Program directors must be qualified investigators capable of leading both the scientific and administrative aspects of the program. Participants supported must generally be U.S. citizens or permanent residents, unless otherwise justified. Applications must be submitted electronically through Grants.gov or NIH ASSIST systems, with tracking through eRA Commons. While a letter of intent is not required, it is encouraged and due thirty days prior to the application deadline. Required application components include a detailed research education program plan, evaluation plan, dissemination strategy, and documentation of institutional support. Applications must adhere strictly to NIH submission guidelines, and incomplete or non compliant applications will not be reviewed. Applications are evaluated through NIH peer review processes based on criteria such as significance, investigator capability, innovation, approach, and environment. Additional considerations include the effectiveness of the educational environment and plans for responsible conduct of research. Review cycles occur annually, with application deadlines typically in March, followed by scientific review in July, advisory council review in October, and earliest project start dates in December. The program operates on a recurring annual cycle, though the current funding announcement expired early on July 8, 2026. Historically, application deadlines have occurred in March each year, indicating an annual cadence. Prospective applicants are advised to monitor NIH communications for reissuance or related opportunities. For inquiries, applicants may contact NIH program staff such as Marguerite Matthews at the National Institute of Neurological Disorders and Stroke via email or phone. Overall, this program represents a significant federal investment in early research education and workforce development in biomedical sciences.

This funding opportunity provides financial support for small-scale cancer research projects that can be completed quickly, targeting a wide range of organizations, including universities, nonprofits, and businesses, to advance cancer prevention, diagnosis, and treatment.

This funding opportunity is designed to support research projects that explore how social factors affect cancer care and outcomes for individuals living with HIV, aiming to reduce health disparities in this population.

Dear Prospective Applicants: The United States Agency for International Development (USAID) is seeking applications for a Cooperative Agreement from qualified entities to implement the above-mentioned Program outlined in the subject NOFO. Eligibility for this award is not restricted. USAID intends to make a single award to the applicant(s) who best meets the objectives of this funding opportunity based on the merit review criteria described in this NOFO subject to a risk assessment. Eligible entities interested in submitting an application are encouraged to read this NOFO thoroughly to understand the type of activity sought, application submission requirements, and selection process. Subject to funding availability, USAID intends to provide up to $13,000,000.00 in total USAID funding to the USAID The Gambia Malaria Elimination Activity (GMEA or activity). To be eligible for award, the applicant must provide all information as required in this NOFO and meet eligibility standards in Section C of this NOFO. This funding opportunity is posted on www.grants.gov, and may be amended. It is the responsibility of the applicant to regularly check the website to ensure they have the latest information pertaining to this notice of funding opportunity and to ensure that the NOFO has been received from the internet in its entirety. USAID bears no responsibility for data errors resulting from transmission or conversion process. If you have difficulty registering on www.grants.gov or accessing the NOFO, please contact the Grants.gov Helpdesk at 1-800-518-4726 or via email at support@grants.gov for technical Assistance. USAID may not award to an applicant unless the applicant has complied with all applicable unique entity identifier and System for Award Management (SAM) requirements detailed in Section D.6.g. The registration process may take many weeks to complete. Therefore, applicants are encouraged to begin registration early in the process. Please send any questions to the point(s) of contact identified in Section G. The deadline for questions is shown above. Responses to questions received prior to the deadline will be furnished to all potential applicants through an amendment to this notice posted to www.grants.gov. Issuance of this notice of funding opportunity does not constitute an award commitment on the part of the Government nor does it commit the Government to pay for any costs incurred in preparation or submission of comments/suggestions or an application. Applications are submitted at the risk of the applicant. All preparation and submission costs are at the applicants expense. Please note that USAID reserves the right to cancel this process at any time without prior notice. Thank you for your interest in USAID programs.` Sincerely,

The goal of the Activity is to improve health outcomes for individuals, health workers, families and communities affected and infected by TB in Zimbabwe. The Activity has four objectives: Objective 1: Improve TB case detection. Objective 2: Strengthen TB case management for all forms of TB. Objective 3: Prevent new TB infections and progression of TB infections to active disease. Objective 4: Strengthen local systems for planning, coordinating, monitoring, and assuring the quality of TB services.

This funding opportunity supports researchers in developing and testing new small molecules that can advance cancer treatment and understanding by creating innovative assays and screening methods.

This funding opportunity supports the establishment of a central hub to enhance collaboration and research on aging and Alzheimer's disease among various research centers, aimed at improving health outcomes and addressing disparities in these areas.

This funding opportunity provides financial support to organizations that aim to enhance survivor involvement in anti-human trafficking programs by developing training, resources, and collaborative networks.

This grant provides funding for researchers to explore how Mycobacterium tuberculosis and HIV affect host cell death pathways, with the goal of developing new therapies to improve treatment outcomes for co-infected individuals.

This funding opportunity provides financial support to a variety of institutions for developing research infrastructure that enhances the study of population dynamics, focusing on issues like fertility, mortality, and migration, particularly as they relate to health outcomes and disparities.

This funding opportunity supports researchers and organizations in developing innovative therapies for eye diseases by providing financial resources for preclinical studies and regulatory preparation.

This funding opportunity provides specialized support to The Goodnation Foundation for improving coordination between correctional facilities and Medicaid services, aiming to enhance healthcare access and reduce recidivism for individuals reentering the community after incarceration.

This funding opportunity supports innovative research into how co-infections contribute to cancer development and disparities, encouraging studies that explore molecular mechanisms, risk factors, and potential biomarkers for early detection.

This funding opportunity provides financial support to a variety of organizations to deliver essential services for victims of abuse facilitated by technology, such as online stalking and image-based sexual abuse.

This grant provides funding to research institutions for collaborative clinical trials focused on innovative prostate cancer treatments, particularly targeting high-risk populations, including military personnel and veterans.

This grant provides salary support for scientists with advanced degrees who contribute specialized expertise to NCI-funded cancer research programs within core facilities, promoting career stability without requiring independent investigator roles.

This program provides funding to enhance nursing education opportunities for individuals from disadvantaged backgrounds, particularly those from underrepresented racial and ethnic groups, to create more inclusive and supportive learning environments.

The purpose of the Coalitions Training Cooperative Agreement is to leverage existing resources and conference support to enable SAMHSA to provide training and technical assistance to state and community prevention leaders, including members of anti-drug community coalitions from around the country who are committed to addressing the evolving needs of the behavioral health field. The award will also help enhance and build the prevention workforce. The program’s aim is to provide evidence-based information on the state of substance use and misuse in the nation to substance use prevention audiences. According to the National Survey on Drug Use and Health (NSDUH) data from 2022, 48.7 million people aged 12 or older (or 17.3% of this population) had a substance use disorder (SUD) in the past year, including 29.5 million who had an alcohol use disorder and 27.2 million who had a drug use disorder. In 2022 the estimates of past year SUD among people aged 12 or older was highest among young adults aged 18 to 25 (27.8% or 9.7 million people) compared to the estimates for all other age groups, and among American Indian or Alaska Native People (24%) compared to the estimates for people in all other racial/ethnic groups.

This funding opportunity supports doctoral candidates conducting research on substance use and addiction, focusing on innovative approaches to prevention, treatment, and health disparities among underserved populations.

This funding opportunity supports small businesses in developing innovative tools and devices to improve the care and management of animals used in research, enhancing their welfare and the efficiency of research facilities.